01, 2026 OSE New Name to be Listed on the OSE Securities OptionsMarket... (hereinafter "OSE") has selected the following underlying securities for securities options and announces the handling of these securities options.
OSE IMMUNOTHERAPEUTICS. NANTES, France, June 24, 2026 - 6.00pm CET - OSE Immunotherapeutics SA (ISIN... Full results are available on the Company's website (www.ose-immuno.com), "Investors - General Shareholders' Meetings" section ... OSE.
Ose Oyamendan, a journalist who had fled to America and joined Amnesty International following the military’s shutdown of the newspaper he wrote for, went on to become a filmmaker, releasing his ...
05, 2026 OSE OSE Expands SingleStockOptions Eligible for Market Making to 50 (Effective August 3, 2026) ... OSE will continue its efforts to improve efficiency in the SSO market in order to meet the needs of market stakeholders.
Tedopi®, pegrizeprument (VEL-101/FR104), lusvertikimab (OSE-127), BI 765063 (OSE-172) and BI 770371, OSE-279 are first-in-class drugs that have no equivalent currently on the market ... OSE Pharma, now ...